Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells

Journal of Immunology

Volumn 173, Issue 2, 2004, Pages 1043-1050

  Roelofs Haarhuis, Karin ^a   Wu, Xianzhu ^a   Gleichmann, Ernst ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NICKEL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL SPREADING; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INFECTION; LYMPHOID CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 3142680192     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.2.1043     Document Type: Article

References (49)

1. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
2. Taniguchi, M., H. Koseki, T. Tokuhisa, K. Masuda, H. Sato, E. Kondo, T. Kawano, J. Cui, A. Perkes, S. Koyasu, and Y. Makino. 1996. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells. Proc. Natl. Acad. Sci. USA 93:11025.
3. Vincent, M. S., J. E. Gumperz, and M. B. Brenner. 2003. Understanding the function of CD1-restricted T cells. Nat. Immunol. 4:517.
4. Wu, D. Y., N. H. Segal, S. Sidobre, M. Kronenberg, and P. B. Chapman. 2003. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198:173.
5. Roark, J. H., S. H. Park, J. Jayawardena. U. Kavita, M. Shannon, and A. Bendelac. 1998. CDL1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121.
6. De Libero, G., and L. Mori. 2003. Self glycosphingolipids: new antigens recognized by autoreactive T lymphocytes. News Physiol. Sci. 18:71.
7. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626.
8. Illes, Z., T. Kondo, J. Newcombe, N. Oka, T. Tabira, and T. Yamamura. 2000. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164:4375.
9. Wilson, S. B., S. C. Kent, K. T. Patton, T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, J. L. Strominger, and D. A. Hafler. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391:177.
10. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J. F. Bach, and R. C. Monteiro. 1998. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831.
11. Burdin, N., L. Brossay, and M. Kronenberg. 1999. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014.
12. Seino, K. I., K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, et al. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98:2577.
13. + Vα14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105:1761.
14. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immume-privileged site. J. Exp. Med. 190:1215.
15. +) T cells are required for oral and portal venous tolerance induction. J. Surg. Res. 104:29.
16. Komagata, Y., and H. L. Weiner. 2000. Oral tolerance. Rev. Immunogenet. 2:61.
17. + T cells expressing CD95 ligand and secreting IL-4 in the liver. J. Immunol. 168:2188.
18. + regulatory T cells by oral antigen administration. J. Immunol. 167:4245.
19. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, and T. L. Delovitch. 2002. Regulation of autoimmune disease by natural killer T cells. J. Mol. Med. 80:290.
20. Cui, J., N. Watanabe, T. Kawano, M. Yamashita, T. Kamata, C. Shimizu, M. Kimura, E. Shimizu, J. Koike, H. Koseki, et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190:783.
21. Ikarashi, Y., R. Mikami, A. Bendelac, M. Terme, N. Chaput, M. Terada, T. Tursz, E. Angevin, F. A. Lemonnier, H. Wakasugi, and L. Zitvogel. 2001. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194:1179.
22. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166:6012.
23. +NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93.
24. Artik, S., K. Haarhuis, X. Wu, J. Begerow, and E. Gleichmann. 2001. Tolerance to nickel: oral nickel administration induces a high frequency of anergic T cells with persistent suppressor activity. J. Immunol. 167:6794.
25. Roelofs-Haarhuis, K., X. Wu, M. Nowak, M. Fang, S. Artik, and E. Gleichmann. 2003. Infectious nickel tolerance: a reciprocal interplay of tolerogenic APCs and T suppressor cells that is driven by immunization. J. Immunol. 171:2863.
26. Artik, S., C. von Vultée, E. Gleichmann, T. Schwarz, and P. Griem. 1999. Nickel allergy in mice: enhanced sensitization capacity of nickel at higher oxidation states. J. Immunol. 163:1143.
27. Graca, L., A. Le Moine, S. P. Cobbold, and H. Waldmann. 2003. Dominant transplantation tolerance. Curr. Opin. Immunol. 15:499.
28. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
29. Dao, T., M. Exley, W. Z. Mehal, S. M. Tahir, S. Snapper, M. Taniguchi, S. P. Balk, and I. N. Crispe. 2001. Involvement of CD1 in peripheral deletion of T lymphocytes is independent of NK T cells. J. Immunol. 166:3090.
30. Suzuki, K., S. Kanamori, K. Takada, and S. Kawana. 2003. Divergence of contact hypersensitivity in vivo compared with hapten-specific lymphocyte proliferation and interferon-γ production in vitro following ultraviolet B irradiation: the possibility that UVB does not affect the sensitizing phase of contact hypersensitivity. Immunology 108:570.
31. Jonuleit, H., E. Schmitt, K. Steinbrink, and A. H. Enk. 2001. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 22:394.
32. Crispe, I. N. 2003. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:51.
33. Gotsman, I., O. Jurim, S. Trop, and Y. Ilan. 2000. Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. Transplant. Proc. 32:749.
34. + T cells, Clin. Immunol. 105:48.
35. Samsonov, D., S. Trop, R. Alper, J. Diment, and Y. Ilan. 2000. Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. J. Hepatol. 32:812.
36. Shlomai, A., S. Trop, I. Gotsman, O. Jurim, J. Diment, R. Alper, E. Rabbani, D. Engelhardt, and Y. Ilan. 2001. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens-bystander effect. J. Pathol. 195:498.
37. Trop, S., D. Samsonov, I. Gotsman, R. Alper, J. Diment, and Y. Ilan. 1999. Liver-associated lymphocytes expressing NKIA are essential for oral immune tolerance induction in a murine model. Hepatology 29:746.
38. Taylor, A. W., P. Alard, D. G. Yee, and J. W. Streilein. 1997. Aqueous humor induces transforming growth factor-β (TGF-β)-producing regulatory T-cells, Curr. Eye Res. 16:900.
39. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32:848.
40. + T regulatory cells following antigen inoculation in an immune-privileged site. J. Immunol. 171:1266.
41. Sonoda, K. H., D. E. Faunce, M. Taniguchi, M. Exley, S. Balk, and J. Stein-Streilein. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42.
42. Stein-Streilein, J., and J. W. Streilein. 2002. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 21:123.
43. D'Orazio, T. J., E. Mayhew, and J. Y. Niederkorn. 2001. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166:26.
44. Wilson, S. B., and T. L. Delovitch. 2003. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3:211.
45. Kim, C. H., E. C. Butcher, and B. Johnston. 2002. Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23:516.
46. Hammond, K. J., and M. Kronenberg. 2003. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15:683.
47. Lee, P. T., A. Putnam, K. Benlagha, L. Teyton, P. A. Gottlieb, and A. Bendelac. 2002. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110:793.
48. + NKT cells and antigen-presenting cells. Int. Immunol. 12:1669.
49. Diehl, L., A. T. Den Boer, E. I. van der Voort, C. J. Melief, R. Offringa, and R. E. Toes. 2000. The role of CD40 in peripheral T cell tolerance and immunity. J. Mol. Med. 78:363.